Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China · Delayed Price · Currency is CNY

11.29

-0.16 (-1.40%)

Jun 18, 2026, 2:25 PM CST

-6.77% (1Y)

Market Cap	8.71B -4.8%
Revenue (ttm)	5.20B +3.3%
Net Income	207.76M +38.9%
EPS	0.27 +35.0%
Shares Out	760.85M
PE Ratio	42.40
Forward PE	23.77
Dividend	0.11 (0.97%)
Ex-Dividend Date	Jun 1, 2026

Volume	5,566,312
Open	10.95
Previous Close	11.45
Day's Range	10.95 - 11.58
52-Week Range	10.73 - 20.37
Beta	0.25
Analysts	Hold
Price Target	17.00 (+50.58%)
Earnings Date	Aug 28, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1993

Employees 5,479

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300171

Full Company Profile

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.

Financial Statements